A cDNA clone of mouse ribosomal protein L27' was shown previously to be 62% identical in amino acid residues to yeast ribosomal protein L29. The L27' cDNA was expressed in yeast to determine the ability of the mouse protein to substitute for yeast L29 in assembling a functional ribosome. In a yeast strain resistant to cycloheximide by virtue of a recessive mutation in the L29 protein, the murine cDNA did not produce a sensitive phenotype, indicating failure of the mouse L27' protein to assemble into yeast ribosomes. However, when the mouse L27' gene was expressed in cells devoid of L29 and otherwise inviable, the murine protein supported normal growth, demonstrating that mouse ribosomal protein L27' indeed was interchangeable with yeast L29. We conclude that mouse ribosomal protein L27' is assembled into ribosomes in yeast, but yeast L29 is assembled preferentially when both L29 and L27' are present in the same cell.
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The ribosome is an organelle whose constituent building blocks have been extensively catalogued. With identification of ribosomal components completed, attention has turned toward deducing the arrangement of the various protein and RNA moieties in the overall structure as well as assigning functions to individual or groups ofribosomal components. A particularly profitable means of determining the function of individual ribosomal components has been through genetic and biochemical analysis of mutants resistant or hypersensitive to inhibitors of protein synthesis (1, 2) . Another approach has been in vitro reconstitution of ribosomes (3); omission of specific ribosomal proteins from reconstitution mixtures often results in absence of a specific function in the completed particles, thereby implicating the missing protein in that function (4) (5) (6) . Although eukaryotic ribosomes have been reconstructed with groups ofribosomal proteins (7) (8) (9) or subunits (10) , reconstitution experiments have been successful primarily with ribosomes of prokaryotic origin, the only type of ribosomes reassembled from totally separated components (3) . Other strategies for determining the function or location of ribosomal components have relied on crossspecies comparisons. Similarities between eukaryotic ribosomal proteins and Escherichia coli ribosomal proteins (e.g., size, charge, or immunological crossreactivity) have been extrapolated to functional similarities (11) (12) (13) . Relationships between ribosomal proteins of different organisms can also be inferred from evolutionarily conserved rRNA domains (14) ; proteins from different organisms that each bind the same rRNA sequence or structure can be assumed to share a similar function and/or location in the ribosome (15) (16) (17) (18) . Finally, deductions from DNA sequences have revealed amino acid homologies among ribosomal proteins from different organisms, homologies that suggest equivalent function (19) (20) (21) (22) (23) (24) (25) .
Cycloheximide is an inhibitor of the peptidyltransferase reaction in eukaryotic ribosomes. In yeast, resistance to cycloheximide results from mutations in the gene CYH2 (26, 27) , which encodes ribosomal protein L29 (28) . Therefore, L29 is believed to be a part of the ribosome's peptidyltransferase center. Recently, Belhumeur et al. (29) of the L27' cDNA sequence was similarly converted to a Kpn I site; the L27' cDNA was then cleaved at a BamHI site 15 bp 5' of the L27' translation start codon and at the newly created Kpn I site 3' of the gene, and the resulting fragment was inserted into pBM150 between the BamHI site 54 bp 3' of the GAL] transcription start and the Kpn I site further downstream. Transcription of L27' was thereby made conditional, since the GAL] promoter is functional only when cells are grown on galactose. A yeast transcription termination sequence was also inserted at the Kpn I site 3' ofthe L27' cDNA; the terminator consisted of a Kpn I-Nru I (converted to Kpn I) fragment derived from the distal portion ofthe yeast CYCI gene contained in plasma pAB16 (kindly provided by F. Sherman, University of Rochester, Rochester, NY). The final construct was designated pBML27'.
High-copy, constitutive expression vector. The BamHIHindIII fragment containing the L27' cDNA was inserted between the BamHI and HindIII sites in the polylinker of pVT102L (33) , placing the L27' gene adjacent to the yeast alcohol dehydrogenase promoter in this high-copy-number plasmid. The promoter is active constitutively.
Analysis of mRNA. Nitrocellulose blot hybridization of yeast RNA was performed as described (30) . Analysis of yeast polyribosomes by sucrose density gradient centrifugation was carried out as described by Warner et al. (34) .
RESULTS
Diploid yeast cells heterozygous for resistance to cycloheximide, designated cyh2/CYH2, where cyh2 represents the resistance allele, display a sensitive phenotype at inhibitor concentrations above 1.0-2.0 ,ug/ml (28) . This fact was used to test the function of mouse ribosomal protein L27' in yeast. The mouse cDNA encoded a wild-type (sensitive) L27' protein; thus, if after introduction of the L27' gene into a cyh2 yeast strain the mouse ribosomal protein was incorporated into yeast ribosomes, transformants were expected to acquire a cycloheximide-sensitive phenotype.
For expression of the mouse L27' coding sequence in yeast, the cDNA was placed adjacent to the GAL] promoter. The GAL) promoter is active only when cells are propagated on galactose (32) . The GALI-L27' gene was introduced on a single-copy plasmid into the cyh2 strain HF194X1. Transformants were replica-plated to either glucose medium or galactose medium, both containing cycloheximide at 5 ,ug/ml, and all transformants grew on both media. This failure to convert the cycloheximide-resistant phenotype of the recipient cells to a sensitive phenotype on galactose demonstrated that mouse ribosomal protein L27' probably did not become incorporated into yeast ribosomes. To be certain that continued growth in the presence of cycloheximide was not due to the mouse ribosomal protein also conferring resistance, we introduced the same plasmid into a CYH2 yeast strain; in this case cells remained sensitive.
We also performed RNA hybridization analysis to be certain that the GALI-L27' hybrid gene was actually transcribed. Total cellular RNA was isolated from transformants grown either in expressing (galactose) or nonexpressing (glucose) conditions, separated by size in denaturing gels, and transferred to nitrocellulose. Fig. 1 shows an autoradiograph of the transferred RNA that was hybridized simultaneously with a 32P-labeled L27' DNA probe and a probe It remained possible that, despite the L27' gene being transcribed, the L27' mRNA was translated inefficiently or not at all. Poor translation was a possibility since, with respect to the AUG initiator codon, the L27' mRNA contained a guanine at the -3 position. The -3 residue in mRNA is believed to influence the efficiency of translational initiation (35) , and in yeast guanine occurs at this position in only 13% of all sequenced mRNAs (75% have adenine; see ref. 36 ). To measure its translational efficiency, the distribution of L27' mRNA on and off polysomes was analyzed. Strains containing the GALI-L27' plasmid were grown on galactose to allow expression of the L27' gene and the total cell contents were separated by sucrose density centrifugation into fractions containing large polysomes, smaller polysomes, monomers, and nonribosomal material ( Fig. 2A) . RNA was isolated from each fraction and hybridized as described above (Fig. 2B) . The majority of mRNA for yeast ribosomal protein L3 was found in the fraction containing large polysomes. The L27' mRNA was also found in the polysome fractions, indicating that it associated with ribosomes and presumably had been translated into protein.
However, in contrast to L3 mRNA, the L27' mRNA also was found in all fractions of the gradient, suggesting that much of the mRNA was not being efficiently translated, perhaps due to inefficient initiation as predicted from the sequence of its 5' untranslated region.
To this point our results indicated that mouse ribosomal protein L27' was not incorporated into yeast ribosomes, although it The L27' cDNA was inserted adjacent to the constitutive alcohol dehydrogenase promoter in plasmid pVT102L (33) , yielding pVTL27'. Both pVTL27' and pVT102L were introduced into HF194GCYHX23; this yeast strain had a chromosomal copy of cyh2 under control of the GALIO promoter (30) and consequently was unable to produce ribosomal protein L29 unless grown on galactose. Fig. 3 shows that X23 cells transformed with pVT102L (lacking the L27' cDNA) grew on galactose but were unable to grow on glucose. However, the same strain transformed with pVTL27' grew on both carbon sources. This result demonstrated that, indeed, mouse ribosomal protein L27' was able to substitute for L29 and lead to formation of functional ribosomes. To demonstrate that L27' had actually become incorporated into the ribosomes, we replica-plated the transformants onto both glucose and galactose media containing cycloheximide at 5 ,g/ml. Recall that the recipient strain possessed the cyh2 allele expressed from the GALIO promoter. On galactose, HF194GCYHX23 carrying the L27' gene grew in the presence ofcycloheximide, as expected since cyh2 was expressed and L27' was shown not to affect cycloheximide resistance when L29 was also produced. However, on glucose plus cycloheximide, a condition in which L29 was not produced, the same cells now failed to grow, implying that mouse ribosomal protein L27' had replaced yeast ribosomal protein L29, the only polypeptide in the host yeast strain capable of conferring cycloheximide resistance. To obtain still further confirmation of functional substitution of L29 by murine L27', transformants were grown in the presence of leucine, a nonselective condition that permitted loss of the LEU2-containing pVTL27' plasmid. All cells that had lost the plasmid, indicated by reversion to leucine auxotrophy, also gave rise to colonies unable to grow on glucose (data not shown). This simultaneous loss of leucine prototrophy and the ability to grow without galactose demonstrated that the plasmid-borne L27' gene had complemented the L29 deficiency.
To assess whether yeast ribosomes assembled with L27' were as efficient as L29-containing ribosomes, we compared the growth rate of HF194GCYHX23 transformed with pVTL27' on galactose and glucose to the growth rate of the same strain transformed with a multicopy plasmid carrying the L29 gene. The growth rates ofthese strains were the same regardless of plasmid or carbon source (data not shown). Thus, at least in the presence of abundant mouse L27', the functioning ofthe ribosome was sufficient to maintain normal growth. Ribosomes assembled with L27' also did not exhibit (38) showed that human ribosomal protein S14 could assemble into ribosomes ofCHO cells. In CHO cells a mutant allele of S14 confers resistance to emetine. Rhoads and Roufa found that introduction of the (wild-type) human S14 gene into emetine-resistant cells converted those cells to emetine sensitivity, indicating that the human counterpart of S14 had assembled into some fraction of the CHO ribosomes. Unlike the assembly of mouse L27' into yeast ribosomes, the human S14 protein was not excluded from assembly in the presence ofthe indigenous CHO S14 protein.
Since exclusion of murine L27' from the yeast ribosome was inferred from maintenance of the cycloheximideresistant phenotype of cyh2 cells transformed with the L27' gene, it could be argued that presence of the drug inadvertently selected for exclusive assembly of L29 so as to remain cycloheximide-resistant. This (39) (40) (41) (42) ; multiple localization sequences facilitate receptor recognition at the nuclear pore (42) . Possibly the murine L27' protein has but one functional yeast nuclear localization sequence (the other, with His -+ Leu, being nonfunctional) and is therefore at a competitive disadvantage during nuclear uptake.
Finally, it should be borne in mind that we did not show the mouse L27' protein actually to have been in the finished yeast ribosome, only that L27' supported growth of an L29-deficient cell. Ribosomes lacking L29 may indeed be functional, as is the case for E. coli ribosomes lacking one of a number of different proteins (43) . Even though L29 does end up as part of the large subunit, inviability due to its absence simply may result from an inability to maintain the proper pathway of ribosome assembly. The evidence in favor of murine L27' actually having become part of the yeast ribosome is the fact that L29-deficient cells, when supplied with L27', were sensitive to cycloheximide. L29 is assumed to be the site of cycloheximide binding to the ribosome, since resistance to the inhibitor results from amino acid substitutions that convert the uncharged Gln-37 of L29 to a charged residue (lysine in one case and glutamic acid in another; refs. 44 and 45) . Replacement at position 37 by a charged residue presumably prevents inhibitor binding. Wild-type L27' possesses an uncharged amino acid at position 37, namely methionine, and it seems reasonable to conclude that sensitivity to cycloheximide was due to the presence of L27' in the ribosome itself.
